Delivery Order SPE2DB25D2203-SPE2DB25FPRGD

Award Date 12/18/24
Potential Completion Date 12/19/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB25D2203
    Indefinite Delivery Contract
  • SPE2DB25D2203-SPE2DB25FPRGD
    Delivery Order

This federal contract award is for the delivery of GARDASIL 9 syringe 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The $2,346.86 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, on December 18, 2024, with a completion date of December 19, 2024. The contract is not designated as a set-aside.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is one of many under that IDC contract, which covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 3/19/25, 9:58 AM